Molina Healthcare Shares Rise to 455th Largest U.S. Volume Amid Analyst Split and Short Surge as Healthcare Sector Grapples with Cost Pressures

Generated by AI AgentAinvest Volume Radar
Tuesday, Sep 9, 2025 6:31 pm ET1min read
Aime RobotAime Summary

- Molina Healthcare (MOH) shares rose 3.41% on Sept. 9, 2025, with $230M volume, ranking 455th in the U.S. market amid a mixed analyst outlook of three buys and 10 holds.

- Despite a 14.71% EPS growth projection and an 8.61 P/E ratio below sector averages, short interest surged 62.04% MoM, with 3.27% of shares sold short and a 1.4 days-to-cover ratio.

- Institutional ownership remains strong at 98.5%, while executives bought $1.56M in shares versus $107K in sales, signaling internal confidence despite Amundi’s 25.9% stake reduction and increased hedge fund buying.

- Rising medical costs pressured healthcare sector margins, forcing Molina to revise earnings downward, contrasting with hedge funds like Rothschild and Elequin boosting positions by 126.3% and 170.6%.

. 9, 2025, , . market. The stock faces a mixed analyst outlook, . , .

, , signaling heightened bearish sentiment. , reflecting confidence in the company’s fundamentals. Insider activity also stood out, , , indicating internal confidence.

Amundi, a major institutional investor, , . This divestment contrasts with increased buying by other hedge funds, including and Elequin Capital, , respectively. The broader healthcare sector faces headwinds, .

To run a daily-rotation strategy buying the 500 highest-volume stocks and closing positions the next day, tools must generate daily ticker lists, trade signals, and aggregate P&L. Current back-testing systems support single-ticker or event-driven tests but lack multi-asset capabilities for large universes. Solutions include narrowing the universe to a fixed index or waiting for advanced portfolio back-testing modules to handle thousands of signals daily.

Hunt down the stocks with explosive trading volume.

Latest Articles

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet